BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
99 | 1863.00 | 1881.00 | 14 |
1 | 1861.60 | 1885.00 | 1 |
1 | 1861.50 | 1886.95 | 14 |
3 | 1861.00 | 1890.00 | 83 |
69 | 1860.00 | 1898.00 | 3 |
0 | Total | Total | 0 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
99 | 1863.00 | 1881.00 | 14 |
1 | 1861.60 | 1885.00 | 1 |
1 | 1861.50 | 1886.95 | 14 |
3 | 1861.00 | 1890.00 | 83 |
69 | 1860.00 | 1898.00 | 3 |
0 | Total | Total | 0 |
Open | 1,900.50 |
Previous Close | 1,892.20 |
Volume | 79,151.00 |
Value (Lacs) | 1,486.53 |
VWAP | 1,876.79 |
Beta | |
Mkt Cap (Rs. Cr.) | 30,943 |
High | 1,909.40 |
Low | 1,856.00 |
UC Limit | 2,270.60 |
LC Limit | 1,513.80 |
52 Week High | 2,131.00 |
52 Week Low | 1,277.80 |
Face Value | 1.00 |
All Time High | 4,350.00 |
All Time Low | 861.00 |
20D Avg Volume | 421,923 |
20D Avg Delivery(%) | 34.23 |
Book Value Per Share | 533.39 |
Dividend Yield | 0.96 |
TTM EPS See historical trend | 46.75 (+5.33% YoY) |
TTM PE See historical trend | 40.17 (Average PE) |
P/B See historical trend | 3.53 (Average P/B) |
Sector PE | 39.39 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
4 out of 5 years Gland Pharma has given negative returns in September.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
September | 0.35% | 0.35% | -11.62% (2022) | -5.55% | -4.37% |
Gland Consolidated June 2025 Net Sales at Rs 1,505.62 crore, up 7.41% Y-o-Y Aug 12 2025 01:07 PM
Buy Gland Pharma; target of Rs 2340: Motilal Oswal Aug 08 2025 02:54 PM
Gland Standalone June 2025 Net Sales at Rs 1,038.84 crore, up 2.65% Y-o-Y Aug 07 2025 10:54 AM
Stocks to Watch Today: NSDL, Sri Lotus Developers, Bharti Airtel, Britannia, Lupin, Prestige Estates, EIH, Gland Pharma, HG Infra in focus on 6 August Aug 06 2025 01:17 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 1016219 | Price 1588.69 | % Traded 0.62 |
Qty 838556 | Price 1588.69 | % Traded 0.51 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Gland | 1,878.10 | -0.75 | 30,942.90 | 27.23 | 3.37 | 11.17 | -1.46 | 1,089 | 4,116 | 0.00 |
Sun Pharma | 1,581.00 | -0.79 | 379,334.86 | 36.57 | 5.49 | 15.13 | -13.35 | 10,980 | 52,578 | 0.03 |
Divis Labs | 6,027.50 | 0.31 | 160,011.19 | 69.39 | 11.67 | 14.63 | 17.32 | 2,191 | 9,360 | 0.00 |
Cipla | 1,541.20 | -0.79 | 124,491.06 | 23.09 | 4.39 | 16.90 | -4.34 | 5,291 | 27,547 | 0.00 |
Torrent Pharma | 3,612.90 | 0.94 | 122,276.95 | 61.08 | 16.29 | 25.17 | 5.74 | 1,911 | 11,516 | 0.40 |